These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Behavioural correlates to the dopamine D-1 and D-2 antagonists. Christensen AV; Arnt J; Hyttel J; Svendsen O Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830 [TBL] [Abstract][Full Text] [Related]
5. Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation. Zhao H; He X; Thurkauf A; Hoffman D; Kieltyka A; Brodbeck R; Primus R; Wasley JW Bioorg Med Chem Lett; 2002 Nov; 12(21):3111-5. PubMed ID: 12372513 [TBL] [Abstract][Full Text] [Related]
6. Is dopamine antagonism a requisite of neuroleptic activity? Greenblatt EN; Coupet J; Rauh E; Szucs-Myers VA Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):105-19. PubMed ID: 6111298 [TBL] [Abstract][Full Text] [Related]
7. Intrastriatal injection of quaternary butyrophenones and oxypertine: neuroleptic effect in rats. Fog R; Randrup A; Pakkenberg H Psychopharmacologia; 1971; 19(3):224-30. PubMed ID: 5105727 [No Abstract] [Full Text] [Related]
8. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent]. Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774 [TBL] [Abstract][Full Text] [Related]
9. The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide. Brown F; Campbell W; Clark MS; Graves DS; Hadley MS; Hatcher J; Mitchell P; Needham P; Riley G; Semple J Psychopharmacology (Berl); 1988; 94(3):350-8. PubMed ID: 3128811 [TBL] [Abstract][Full Text] [Related]
10. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics. Barghon R; Protais P; Colboc O; Costentin J Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489 [TBL] [Abstract][Full Text] [Related]
11. 2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 1. van Wijngaarden I; Kruse CG; van Hes R; van der Heyden JA; Tulp MT J Med Chem; 1987 Nov; 30(11):2099-104. PubMed ID: 2889830 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects. Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833 [No Abstract] [Full Text] [Related]
13. Evidence for a noradrenergic and dopaminergic mechanism in the hyperactivity produced by 4, alpha-dimethyl-m-tyramine (H 77-77) in rats. Lassen JB Psychopharmacologia; 1974; 37(4):331-40. PubMed ID: 4136728 [No Abstract] [Full Text] [Related]
14. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents. Norman MH; Rigdon GC; Navas F; Cooper BR J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539 [TBL] [Abstract][Full Text] [Related]
15. [Neuroleptics with prolonged action]. Cervantes León G Neurol Neurocir Psiquiatr; 1976; 17(1):35-45. PubMed ID: 29246 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacologic and clinical properties of a new butyrophenone derivative (FR 33)]. Kuhn R; Taeschler M; Schoch J Psychopharmacologia; 1966; 9(4):351-62. PubMed ID: 4871475 [No Abstract] [Full Text] [Related]